Hepatitis Hepatitis  The estimated prevalence of NASH in the world is 3–5%.   Of NASH patients who develop cirrhosis, about 2% per year will likely progress to hepatocellular carcinoma.    Worldwide, the estimated prevalence of hepatocellular carcinoma related to NAFLD is 15–30%.  NASH is thought to be the primary cause of cirrhosis in approximately 25% of patients in the United States, representing 1–2% of the general population. Initial accounts of a syndrome that we now think is likely to be hepatitis begin to occur around 3000 B. C.   Clay tablets that served as medical handbooks for the ancient Sumerians described the first observations of jaundice Hepatitis Hepatitis